Literature DB >> 20526018

Spontaneous clearance of hepatitis C infection post-liver transplant: A rare but real phenomenon? A case report and review of the literature.

Mazhar Haque1, Almoutaz Hashim, Erica D Greanya, Urs P Steinbrecher, Siegfried R Erb, Eric M Yoshida.   

Abstract

Recurrent hepatitis C virus (HCV) infection after liver transplantation is a significant cause of morbidity, mortality and graft loss. Spontaneous clearance of recurrent HCV after liver transplant is a rarely reported phenomenon. We report a case of a 66-year-old woman who underwent liver transplantation for HCV cirrhosis (treatment- naive genotype 2) under immunosuppression with tacrolimus, mycophenolate mofetil (MMF), and short-term corticosteroids. The patient developed histologically proved severe cholestatic recurrence of HCV hepatitis. Immunosuppression was reduced to tacrolimus monotherapy because of cytopenia. She subsequently became RNA negative at week 44 post- transplant while on tacrolimus and MMF despite no antiviral therapy. A spontaneous sustained virologic clearance was confirmed with subsequent HCV nucleotide testing. Only a few similar cases have been reported in the literature with uninterrupted immunosuppression and subsequent spontaneous clearance. Our experience, and the few other published cases in the literature, suggests that spontaneous clearance of HCV after liver transplantation is a rare but real phenomenon. Better understanding of this phenomenon may help to manage recurrent HCV disease after transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20526018

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  6 in total

1.  Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient.

Authors:  Anil B Seetharam; Brian B Borg; Vijay Subramanian; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

2.  Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.

Authors:  Emily Bethea; Ashwini Arvind; Jenna Gustafson; Karin Andersson; Daniel Pratt; Irun Bhan; Michael Thiim; Kathleen Corey; Patricia Bloom; Jim Markmann; Heidi Yeh; Nahel Elias; Shoko Kimura; Leigh Anne Dageforde; Alex Cuenca; Tatsuo Kawai; Kassem Safa; Winfred Williams; Hannah Gilligan; Meghan Sise; Jay Fishman; Camille Kotton; Arthur Kim; Christin C Rogers; Sarah Shao; Mariesa Cote; Linda Irwin; Paul Myoung; Raymond T Chung
Journal:  Am J Transplant       Date:  2020-02-03       Impact factor: 8.086

3.  Spontaneous clearance of HCV accompanying hepatitis after liver transplantation.

Authors:  Tomomi Kogiso; Etsuko Hashimoto; Yuichi Ikarashi; Kazuhisa Kodama; Makiko Taniai; Nobuyuki Torii; Hiroto Egawa; Masakazu Yamamoto; Katsutoshi Tokushige
Journal:  Clin J Gastroenterol       Date:  2015-09-05

4.  Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility.

Authors:  Israr-Ul H Ansari; Todd Allen; Andrew Berical; Peter G Stock; Burc Barin; Rob Striker
Journal:  Virology       Date:  2013-01-02       Impact factor: 3.616

5.  Learning from a rare phenomenon - spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report.

Authors:  Noreen Singh; Mang Ma; Aldo J Montano-Loza; Rahima A Bhanji
Journal:  World J Hepatol       Date:  2022-02-27

6.  Spontaneous clearance of hepatitis C virus after liver transplantation: a report of four cases.

Authors:  Ichiro Tamaki; Toshimi Kaido; Shintaro Yagi; Yoshihide Ueda; Etsuro Hatano; Hideaki Okajima; Shinji Uemoto
Journal:  Surg Case Rep       Date:  2015-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.